ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance.

Toshiya Abe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.